Travere Therapeutics (TVTX) Beats Q4 Earnings Estimates by $0.13

Travere Therapeutics (NASDAQ:TVTX) reported quarterly earnings results on February 19, 2026 that exceeded analyst expectations.

The Healthcare company reported earnings per share of $0.37, beating the consensus estimate of $0.24 by $0.13 per share. Revenue came in at $129.7M, missing the estimate of $145.6M.

Travere Therapeutics's stock moved following the earnings release. The stock currently trades at $29.01 with a market capitalization of $3.1B.